Lv6
1720 积分 2023-10-04 加入
Comparison of the O-RADS and ADNEX models regarding malignancy rate and validity in evaluating adnexal lesions
8个月前
已完结
Comparison of O-RADS 2022 and Simple Rules Ultrasound Classifications to Predict Adnexal Malignancy
9个月前
已完结
O-RADS US: A Systematic Review and Meta-Analysis of Category-specific Malignancy Rates
11个月前
已完结
Clinical value of O-RADS combined with serum CA125 and HE4 for the diagnosis of ovarian tumours
11个月前
已完结
Does Combing O‐RADS US and CA ‐125 Improve Diagnostic Accuracy in Assessing Adnexal Malignancy Risk in Women With Different Menopausal Status?
11个月前
已完结
O-RADS US Risk Stratification and Management System: Case-based Learning Approach for Daily Practice
11个月前
已完结
Diagnostic performance of IOTA SR and O-RADS combined with CA125, HE4, and risk of malignancy algorithm to distinguish benign and malignant adnexal masses
1年前
已完结
The Value of IOTA Simple Rules Combined With CEUS Scoring System in the Diagnosis of Benign and Malignant Ovarian Masses and Its Correlation With MVD and VEGF: A Preliminary Study
1年前
已完结
Contrast-enhanced US to Improve Diagnostic Performance of O-RADS US Risk Stratification System for Malignancy
1年前
已完结
皖公网安备34019202002308
